SCHEMBL23950982

SCHEMBL23950982

CC(CNC(=O)OC(C)(C)C)n1cnc2c(-c3cccnc3)nc(Cl)cc2c1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.37
PCSK9 Q8NBP7 1/20 0.37
CCNE2 O96020 1/20 0.37
CCNA2 P20248 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37
IDO1 P14902 1/20 0.36
CYP3A4 P08684 1/20 0.36
KIT P10721 1/20 0.35
EGLN1 Q9GZT9 5/20 0.35
GBA1 P04062 1/20 0.35
NAMPT P43490 1/20 0.35
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
DYRK1A Q13627 1/20 0.33
AAK1 Q2M2I8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30101944 0.91 HTT (0.36) HTTPCSK9CCNE2CCNA2CCNE1
SCHEMBL23925644 0.89 EGLN1 (0.41) EGLN1DYRK1A
SCHEMBL23951122 0.86 EGLN1 (0.38) HTTCCNE2CCNA2CCNE1CDK2
SCHEMBL23390216 0.83 KDM5B (0.37) CCNA2CDK2CCNA1CYP3A4EGLN1
SCHEMBL23390213 0.83 KDM5B (0.37) CCNA2CDK2CCNA1CYP3A4EGLN1
SCHEMBL23950983 0.81 KDM5B (0.37) CCNA2CDK2CCNA1CYP3A4EGLN1
SCHEMBL23950740 0.81 STK17B (0.35) PCSK9CCNE2CCNA2CCNE1CDK2
SCHEMBL26276200 0.81 KDM5B (0.37) CCNA2CCNE1CDK2CCNA1CYP3A4
SCHEMBL26276204 0.81 KDM5B (0.37) CCNA2CCNE1CDK2CCNA1CYP3A4
SCHEMBL23925833 0.79 EGLN1 (0.38) HTTCYP3A4EGLN1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 US disclosed
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 US disclosed
EP-4136088-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS Dong-A ST Co., Ltd. (KR) 2023-02-22 EP disclosed
CN-115443276-A Pyridopyrimidinone derivatives and their use as modulators of aromatic hydrocarbon receptors 东亚ST株式会社 2022-12-06 CN disclosed
WO-2021210970-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, AIPL1 HTT 855/4885PCSK9 3090/4885CCNE2 2713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.